Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

Rat Poison and Biotech in Cuba

Since long before Fidel Castro came on the scene, Cuba has fostered a tradition of respected scientific research. Even now, the island nation markets biotech products around the world. Although a long-running embargo prohibits their coming to the US, a meningitis vaccine may be on the way. We'll hear from a New York minister, who wants to mix politics and science by importing a Cuban rat poison that's already used in some countries. We'll talk about Cuba's biotech products with medical researchers and trade monitors, and get an update on Castro himself. Newsmaker: Blue Cross to Tie Bonuses to Patient Satisfaction - California's fourth largest HMO will replace cost cutting with patient satisfaction as a basis for physician bonuses. Mark Hagland, former executive editor of Hospitals and Health Network magazine, analyzes Blue Cross' change of heart and what the change in cost control techniques will mean for patients, doctors and HMO's. Reporter's Notebook: Baseball's All-Star Game and Japanese Heroes Deserting Japan - The player with the most votes for tonight's all-star game is Ichiro Suzuki, the electrifying left-fielder who's led the Mariners to more wins this year than any other team. But Joanie Balter, of the Seattle Times, warns that Seattle's gain is Japan's loss, as he and a trail of cultural heroes abandon their country and its faltering economy.

  • rss
  • Share
By Warren Olney • Jul 10, 2001 • 1 min read

Since long before Fidel Castro came on the scene, Cuba has fostered a tradition of respected scientific research. Even now, the island nation markets biotech products around the world. Although a long-running embargo prohibits their coming to the US, a meningitis vaccine may be on the way. We'll hear from a New York minister, who wants to mix politics and science by importing a Cuban rat poison that's already used in some countries. We'll talk about Cuba's biotech products with medical researchers and trade monitors, and get an update on Castro himself.

  • Newsmaker:

    Blue Cross to Tie Bonuses to Patient Satisfaction - California's fourth largest HMO will replace cost cutting with patient satisfaction as a basis for physician bonuses. Mark Hagland, former executive editor of

    Hospitals and Health Network magazine, analyzes Blue Cross' change of heart and what the change in cost control techniques will mean for patients, doctors and HMO's.

  • Reporter's Notebook:

    Baseball's All-Star Game and Japanese Heroes Deserting Japan - The player with the most votes for tonight's all-star game is Ichiro Suzuki, the electrifying left-fielder who's led the Mariners to more wins this year than any other team. But Joanie Balter, of the

    Seattle Times, warns that Seattle's gain is Japan's loss, as he and a trail of cultural heroes abandon their country and its faltering economy.

Blue Cross of California

Hospitals and Health Network

WellPoint Health Networks

Inter-Religious Foundation for Community Organization/Pastors for Peace

Office of Foreign Assets Control

Talk

US Cuba Trade and Economic Council

Seattle Mariners

The Seattle Times

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Warren Olney

    former KCRW broadcaster

    NewsNationalPolitics
Back to To the Point